Context Therapeutics, Inc. (CNTX)

2.45 +0.17 (+7.46%) USD  |  NASDAQ  |  Feb 24, 14:48
More

Context Therapeutics EPS Diluted from Accounting Change (Quarterly)

EPS Diluted from Accounting Change (Quarterly) Chart

View EPS Diluted from Accounting Change (Quarterly) for CNTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Accounting Change (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Accounting Change (Quarterly) Benchmarks

View EPS Diluted from Accounting Change (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
Savara, Inc. --
BioMarin Pharmaceutical, Inc. --
Imunon, Inc. --